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Conclusion: Anti-cardiolipin antibodies are associated with cancer
mortality but not vascular mortality.
Summary: There is an association between anticardiolipin antibodies
and venous and arterial thrombosis. A direct association between anticardio-
lipin antibodies and vascular mortality has not been proven. The authors
therefore evaluated anticardiolipin antibodies for their influence on vascular
and oncology mortality. There were 4756 patients whose anticardiolipin
antibodies were measured between October 2002 and February 2004. The
median age was 46 years, and 64% were women. The study was conducted in
Austria, and death, survival, and cause of death data were obtained from the
Austrian death registry. There were 7189 person years in the study, and the
median period of observation was 1.5 years per patient.
Over the course of the study, 3.9% (184) of patients died. In patients
with positive anticardiolipin antibodies, either immunoglobulin (Ig) M or
IgG, the risk of cancer related mortality increased 2.6 times. In a Cox
regression analysis adjusted for age and sex, there were no associations
between anticardiolipin levels of IgM or IgG antibodies in either vascular
death or noncancer mortality.
Comment: The literature describes a clear association between primar-
ily nonfatal vascular events and anti-cardiolipin antibodies. The authors’ data
indicates that whereas patients with elevated IgM or IgG levels may have
increased vascular events, it does not appear to affect vascular related
mortality. This study is limited by the fact that anticardiolipin antibodies
measurements can be affected by interactions with plasma lipids and
lipids were not measured in this study. In addition, a period of observa-
tion of a median of 1.5 years per patient is relatively short for mortality
observations.
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